MJ Biz Con 2016 – Astounding Success for the Cannabis Industry

By | Business | No Comments

MLast week, thousands of cannabis industry professionals came to Las Vegas for the 5th Annual Marijuana Business Conference. It is by far the longest running, biggest and most respected cannabis trade show event – featuring the industry’s leading entrepreneurs, advocates and investors – and is growing each year at an astounding rate.

I had never attended this conference before. While I genuinely enjoy and thrive in networking situations, this one was big enough even I had a hard time keeping up. However, although it may have been slightly overwhelming for some, the attendance and enthusiasm that was apparent in the atmosphere at the conference was absolutely inspiring. There were 10,881 attendees this year, almost double what the conference saw last year in 2015, where there was 5,561 attendees. The conference sold out certain items starting on Tuesday (11/15), but most rolled into Wednesday.

“The demand for attendance exceeded our expectations. We were able to accommodate as many people as the rooms would fit,” said Marijuana Business Daily. I think we exceeded the expectations of many…who knew this would almost double in size in a year’s time?

read more

Medical marijuana producer Canopy Growth Corp. expands as client base grows

By | Business | No Comments

Medical marijuana producer Canopy Growth Corp. has been expanding its growing facilities to keep up with demand, as the company’s client base grew 47 per cent during the quarter.

Canopy (TSX:CGC) says it had over 24,400 registered patients at the end of September, up from over 16,600 during the previous quarter and 6,200 a year ago.

The company released the new patient figures as it reported a profit of $5.4 million or a nickel per diluted share for the quarter ended Sept. 30.

The result compared with a profit of $3.9 million or a nickel per diluted share in the same quarter last year when it had fewer shares outstanding.

Revenue in what was its second quarter totalled nearly $8.5 million, up from nearly $2.5 million in the same quarter last year.

During a conference call to discuss the company’s quarterly results, CEO Bruce Linton emphasized the company’s efforts to expand its production capacity to keep up with demand.

Canopy expects to more than double the amount of marijuana it’s producing at its Smiths Falls facility over the next six months, Linton said.

read more

The single most important pitfall to avoid with legalizing marijuana

By | Business | No Comments

This November, voters in nine states will consider proposals to legalize medical and/or recreational marijuana. The tide has turned, and cannabis is on its way to becoming a legal part of the American landscape—federal law be damned. But experiences in states like Washington and Colorado suggest that without additional regulation, measures meant to make the drug more accessible can wind up hurting the people who need it most.
Marijuana occupies a complex place in the American social and legal landscape in part because of its seemingly contradictory uses. Some people (Snoop Dogg, the Dude) use it to relax and get a buzz. Others use it to treat issues like pain, nausea, glaucoma, and seizures. These two groups are looking for very different things in their marijuana products. For those in the latter group, the last thing they want is a high—they need a drug that will allow them to work, care for their families, and go about their daily business.
This means that medical patients, by and large, are typically looking for drugs with a high cannabidiol (CBD) content and a low

read more

What You Need to Know About Voting for Medical Marijuana on Nov. 8

By | Featured | No Comments

Currently 25 states and the District of Columbia have medical cannabis programs. On Nov. 8, Arkansas, Florida and North Dakota will vote on medical cannabis ballot initiatives, while Montana will vote on repealing limitations in its existing law.

We have no political position on cannabis legalization. We study the cannabis plant, also known as marijuana, and its related chemical compounds. Despite claims that cannabis or its extracts relieve all sorts of maladies, the research has been sparse and the results mixed. At the moment, we just don’t know enough about cannabis or its elements to judge how effective it is as a medicine.

What does the available research suggest about medical cannabis, and why do we know so little about it?

read more